Palisade Bio CMO Mitch Jones, MD, PhD, to Present at 8th Annual Antifibrotic Drug Development (AFDD) Summit
Palisade Bio (Nasdaq: PALI) announced its participation in the 8th Annual Antifibrotic Drug Development Summit in Boston, MA, from November 19-21, 2024. Chief Medical Officer Mitch Jones, MD, PhD, will present on fibrostenotic Crohn's Disease and local PDE4 inhibitor prodrug development on November 21 at 2:30 PM ET.
The presentation, titled 'Detailing Characteristics of Fibrostenotic Crohn's Disease Biology & the Potential of a Local PDE4 Inhibitor Prodrug to Minimize Off-Target Effects & Maximize Efficacy,' will be part of the session examining latest research in antifibrotic development. The AFDD Summit is a key forum bringing together experts in antifibrotic drug development.
Palisade Bio (Nasdaq: PALI) ha annunciato la sua partecipazione all'8° Annual Antifibrotic Drug Development Summit che si svolgerà a Boston, MA, dal 19 al 21 novembre 2024. Il Direttore Medico Mitch Jones, MD, PhD presenterà un intervento sulla malattia di Crohn fibrostenotica e sullo sviluppo di pro-farmaci inibitori PDE4 locali il 21 novembre alle 14:30 ET.
La presentazione, intitolata 'Caratteristiche della Biologia della Malattia di Crohn Fibrostenotica e il Potenziale di un Pro-Farmaco Inibitore PDE4 Locale per Minimizzare gli Effetti Off-Target e Massimizzare l'Efficacia,' farà parte della sessione che esamina le ultime ricerche nello sviluppo antifibrotico. Il Summit AFDD è un'importante forum che riunisce esperti nello sviluppo di farmaci antifibrotici.
Palisade Bio (Nasdaq: PALI) anunció su participación en el 8° Cumbre Anual de Desarrollo de Medicamentos Antifibróticos en Boston, MA, del 19 al 21 de noviembre de 2024. El Director Médico Mitch Jones, MD, PhD presentará sobre la Enfermedad de Crohn fibrostenótica y el desarrollo de profármacos inhibidores de PDE4 locales el 21 de noviembre a las 2:30 PM ET.
La presentación, titulada 'Detallando Características de la Biología de la Enfermedad de Crohn Fibrostenótica y el Potencial de un Profármaco Inhibidor de PDE4 Local para Minimizar Efectos Fuera del Objetivo y Maximizar la Eficacia,' formará parte de la sesión que examina las últimas investigaciones en desarrollo antifibrótico. La Cumbre AFDD es un foro clave que reúne a expertos en el desarrollo de medicamentos antifibróticos.
팔리세이드 바이오 (Nasdaq: PALI)는 2024년 11월 19일부터 21일까지 매사추세츠주 보스턴에서 열리는 제8회 연례 항섬유화 약물 개발 정상 회담에 참가한다고 발표했습니다. 미치 존스 박사가 11월 21일 오후 2시 30분(ET)에 섬유협착형 크론병 및 국소 PDE4 억제자 전구약물 개발에 대해 발표할 예정입니다.
'섬유협착형 크론병 생물학의 특성 및 국소 PDE4 억제 전구약물이 표적 외 효과를 최소화하고 효능을 극대화할 가능성'이라는 제목의 발표는 항섬유화 개발의 최신 연구를 검토하는 세션의 일환으로 진행됩니다. AFDD 정상 회담은 항섬유화 약물 개발 분야의 전문가들을 한자리로 모으는 중요한 포럼입니다.
Palisade Bio (Nasdaq: PALI) a annoncé sa participation au 8ème Sommet Annuel sur le Développement de Médicaments Antifibrotiques à Boston, MA, du 19 au 21 novembre 2024. Le Directeur Médical Mitch Jones, MD, PhD présentera sur la maladie de Crohn fibrostenotique et le développement de pro-médicaments inhibiteurs de PDE4 locaux le 21 novembre à 14h30 ET.
La présentation, intitulée 'Détail des Caractéristiques de la Biologie de la Maladie de Crohn Fibrostenotique et le Potentiel d'un Pro-Médicament Inhibiteur de PDE4 Local pour Minimiser les Effets Hors Cible et Maximiser l'Efficacité,' fera partie de la session examinant les dernières recherches sur le développement antifibrotique. Le Sommet AFDD est un forum clé réunissant des experts en développement de médicaments antifibrotiques.
Palisade Bio (Nasdaq: PALI) hat seine Teilnahme am 8. Jährlichen Gipfel zur Entwicklung antifibrotischer Medikamente in Boston, MA, vom 19. bis 21. November 2024 bekannt gegeben. Der Chief Medical Officer Mitch Jones, MD, PhD wird am 21. November um 14:30 Uhr ET über die fibrostenotische Morbus Crohn und die Entwicklung lokaler PDE4-Inhibitor-Prodrugs präsentieren.
Die Präsentation mit dem Titel 'Detaillierung der Eigenschaften der Biologie der fibrostenotischen Morbus Crohn & das Potenzial eines lokalen PDE4-Inhibitor-Prodrugs zur Minimierung von Off-Target-Effekten und Maximierung der Wirksamkeit' wird Teil der Sitzung sein, die die neuesten Forschungen in der antifibrotischen Entwicklung untersucht. Der AFDD-Gipfel ist ein wichtiges Forum, das Experten auf dem Gebiet der Entwicklung antifibrotischer Medikamente zusammenbringt.
- None.
- None.
Presentation to highlight advances in fibrostenotic Crohn’s Disease and the potential of localized PDE4 inhibition
Carlsbad, CA, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a clinical-stage biopharmaceutical company focused on developing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic disease, today announced that it has been invited to present at the 8th Annual Antifibrotic Drug Development (AFDD) Summit, being held November 19-21, 2024, in Boston, MA.
Details of the presentation details are as follows:
Title: Detailing Characteristics of Fibrostenotic Crohn’s Disease Biology & the Potential of a Local PDE4 Inhibitor Prodrug to Minimize Off-Target Effects & Maximize Efficacy
Presenter: Mitch Jones, MD, PhD, Chief Medical Officer of Palisade Bio
Session: Examining the Latest Research & Development in Antifibrotic Research & Development
Date and Time: November 21, 2024 from 2:30-3:00 PM ET
The AFDD Summit is a leading forum for experts in the field of antifibrotic drug development, bringing together clinicians, researchers, and pharmaceutical leaders to discuss the latest advancements in treating fibrosis-related diseases. For more information about the AFDD Summit, please visit the conference website.
About Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The Company believes that by using a targeted approach with its novel therapeutics it will transform the treatment landscape. For more information, please go to www.palisadebio.com.
Investor Relations Contact
JTC Team, LLC
Jenene Thomas
908-824-0775
PALI@jtcir.com
FAQ
When is Palisade Bio (PALI) presenting at the 2024 AFDD Summit?
What is the topic of Palisade Bio's (PALI) presentation at the 2024 AFDD Summit?
Who will be presenting for Palisade Bio (PALI) at the 2024 AFDD Summit?
Where is the 2024 AFDD Summit being held?
